Laura Pitlik - 04 Apr 2023 Form 4 Insider Report for Arcadia Biosciences, Inc. (RKDA)

Role
Chief Marketing Officer
Signature
Laura Pitlik, by Attorney-in-fact, Solaeta Chan
Issuer symbol
RKDA
Transactions as of
04 Apr 2023
Net transactions value
$0
Form type
4
Filing time
28 Apr 2023, 17:30:32 UTC
Previous filing
18 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RKDA Stock Option (Right to Buy) Award $0 +1,500 +39% $0.000000 5,300 04 Apr 2023 Common Stock 1,500 $7.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on 4/4/2023 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.